The role of gastrointestinal pathogens in inflammatory bowel disease: a systematic review
暂无分享,去创建一个
[1] Shannon Chang,et al. Comparative Evaluation of Conventional Stool Testing and Multiplex Molecular Panel in Outpatients With Relapse of Inflammatory Bowel Disease. , 2021, Inflammatory bowel diseases.
[2] A. Paterson,et al. Increased Intestinal Permeability is Associated with Later Development of Crohn's Disease. , 2020, Gastroenterology.
[3] K. Cadwell,et al. Systematic review: gastrointestinal infection and incident inflammatory bowel disease , 2020, Alimentary pharmacology & therapeutics.
[4] S. Shah,et al. Friend or Foe in IBD Pathogenesis: Not All Infections are Equal. , 2019, Gastroenterology.
[5] J. Hugot,et al. Is Crohn Disease the price to pay today for having survived to the Black Death? , 2019, Journal of Crohn's & colitis.
[6] R. Peek,et al. Systematic review with meta‐analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease , 2019, Alimentary pharmacology & therapeutics.
[7] J. Ludvigsson,et al. Gastrointestinal Infection Increases Odds of Inflammatory Bowel Disease in a Nationwide Case-Control Study. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[8] S. Targan,et al. Malassezia Is Associated with Crohn's Disease and Exacerbates Colitis in Mouse Models. , 2019, Cell host & microbe.
[9] J. Hugot,et al. Prevalence of Yersinia Species in the Ileum of Crohn's Disease Patients and Controls , 2018, Front. Cell. Infect. Microbiol..
[10] K. Cadwell,et al. Enteric Infections Are Common in Patients with Flares of Inflammatory Bowel Disease , 2018, The American Journal of Gastroenterology.
[11] Feng Chen,et al. Trichuris suis ova therapy in inflammatory bowel disease , 2018, Medicine.
[12] J. Miyoshi,et al. The evidence for fungus in Crohn’s disease pathogenesis , 2018, Clinical Journal of Gastroenterology.
[13] J. del Valle-Mendoza,et al. Helicobacter pylori and its relationship with variations of gut microbiota in asymptomatic children between 6 and 12 years , 2018, BMC Research Notes.
[14] H. Sokol,et al. Specificities of the intestinal microbiota in patients with inflammatory bowel disease and Clostridium difficile infection , 2018, Gut microbes.
[15] V. Nizet,et al. Recurrent infection progressively disables host protection against intestinal inflammation , 2017, Science.
[16] Vanessa M. Hubbard-Lucey,et al. Autophagy protein ATG16L1 prevents necroptosis in the intestinal epithelium , 2017, The Journal of experimental medicine.
[17] Jana G Hashash,et al. Lasting Impact of Clostridium difficile Infection in Inflammatory Bowel Disease: A Propensity Score Matched Analysis , 2017, Inflammatory bowel diseases.
[18] X. Qiu,et al. Alterations in the mucosa-associated fungal microbiota in patients with ulcerative colitis , 2017, Oncotarget.
[19] S. Oka,et al. PCR detection of human herpesviruses in colonic mucosa of individuals with inflammatory bowel disease: Comparison with individuals with immunocompetency and HIV infection , 2017, PloS one.
[20] S. Ng,et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. , 2017, Gastroenterology.
[21] Y. Nobel,et al. Enteric Infection in Relapse of Inflammatory Bowel Disease: The Utility of Stool Microbial PCR Testing , 2017, Inflammatory bowel diseases.
[22] W. Agace,et al. Diversity and functions of intestinal mononuclear phagocytes , 2017, Mucosal Immunology.
[23] J. Langhorst,et al. A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn’s Disease , 2016, Journal of Crohn's & colitis.
[24] A. Bianchi,et al. Gastric transposition as a valid surgical option for esophageal replacement in pediatric patients: experience from three Italian medical centers. , 2017, Gastroenterology report.
[25] B. Shah,et al. Clostridium difficile Infection in Inflammatory Bowel Disease: A Nursing-Based Quality Improvement Strategy , 2016, Journal for healthcare quality : official publication of the National Association for Healthcare Quality.
[26] A. McGeer,et al. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study , 2016, The American Journal of Gastroenterology.
[27] N. Zmora,et al. The microbiome and innate immunity , 2016, Nature.
[28] T. Lobaton,et al. Bacterial Intestinal Superinfections in Inflammatory Bowel Diseases Beyond Clostridum difficile , 2016, Inflammatory bowel diseases.
[29] H. Nielsen,et al. Optimized cultivation of Campylobacter concisus from gut mucosal biopsies in inflammatory bowel disease , 2016, Gut Pathogens.
[30] Ta-Chiang Liu,et al. Genetics and Pathogenesis of Inflammatory Bowel Disease. , 2016, Annual review of pathology.
[31] Martin J. Blaser,et al. Helminth infection promotes colonization resistance via type 2 immunity , 2016, Science.
[32] A. Roy,et al. Clostridium difficile Infection: A Rarity in Patients Receiving Chronic Antibiotic Treatment for Crohn's Disease , 2016, Inflammatory bowel diseases.
[33] G. Liguori,et al. Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients. , 2016, Journal of Crohn's & colitis.
[34] G. Daskalopoulos,et al. The Association of Mycobacterium avium subsp. paratuberculosis with Inflammatory Bowel Disease , 2016, PloS one.
[35] Hugues Aschard,et al. Fungal microbiota dysbiosis in IBD , 2016, Gut.
[36] Z. Arora,et al. Risk factors and clinical implication of superimposed Campylobacter jejuni infection in patients with underlying ulcerative colitis , 2015, Gastroenterology report.
[37] N. Kaakoush,et al. Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis , 2015, Gut.
[38] Eric Z. Chen,et al. Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease. , 2015, Cell host & microbe.
[39] Jonathan Braun,et al. Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases. , 2015, Gastroenterology.
[40] T. Monaghan,et al. Pathogenesis of Clostridium difficile Infection and Its Potential Role in Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.
[41] F. Bushman,et al. Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease , 2015, Inflammatory Bowel Diseases.
[42] D. Littman,et al. The functional impact of the intestinal microbiome on mucosal immunity and systemic autoimmunity , 2015, Current opinion in rheumatology.
[43] J. Turner,et al. Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease , 2015, Mucosal Immunology.
[44] Fang-yu Wang,et al. Helicobacter pylori infection and inflammatory bowel disease in Asians: a meta-analysis. , 2015, World journal of gastroenterology.
[45] G. Liguori,et al. Gut Fungal Microbiota: The Yin and Yang of Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.
[46] M. Ghannoum,et al. Mycobiota in gastrointestinal diseases , 2015, Nature Reviews Gastroenterology &Hepatology.
[47] Jenny Sauk,et al. Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease , 2015, Cell.
[48] E. Bouza,et al. Listeria monocytogenes infection in inflammatory bowel disease patients: case series and review of the literature , 2014, European journal of gastroenterology & hepatology.
[49] M. Yazdanbakhsh,et al. Helminth therapy or elimination: epidemiological, immunological, and clinical considerations. , 2014, The Lancet. Infectious diseases.
[50] Si Ming Man,et al. Role of Emerging Campylobacter Species in Inflammatory Bowel Diseases , 2014, Inflammatory bowel diseases.
[51] S. Naser,et al. Mycobacterium avium subspecies paratuberculosis causes Crohn's disease in some inflammatory bowel disease patients. , 2014, World journal of gastroenterology.
[52] A. Kostic,et al. The microbiome in inflammatory bowel disease: current status and the future ahead. , 2014, Gastroenterology.
[53] F. Carrat,et al. The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease , 2014, Alimentary pharmacology & therapeutics.
[54] P. Bager,et al. Helminth therapy (worms) for induction of remission in inflammatory bowel disease. , 2014, The Cochrane database of systematic reviews.
[55] Jie-shou Li,et al. Dysbiosis of Gut Fungal Microbiota is Associated With Mucosal Inflammation in Crohn’s Disease , 2013, Journal of clinical gastroenterology.
[56] K. Carroll,et al. Clostridium difficile Carriage and Serum Antitoxin Responses in Children with Inflammatory Bowel Disease , 2013, Inflammatory bowel diseases.
[57] R. Fedorak,et al. Prevalence of Epstein–Barr Virus in a population of patients with inflammatory bowel disease: a prospective cohort study , 2013, Alimentary pharmacology & therapeutics.
[58] A. Kalergis,et al. Role of Salmonella enterica exposure in Chilean Crohn's disease patients. , 2013, World journal of gastroenterology.
[59] H. Sewell,et al. Circulating Antibody and Memory B-Cell Responses to C. difficile Toxins A and B in Patients with C. difficile-Associated Diarrhoea, Inflammatory Bowel Disease and Cystic Fibrosis , 2013, PloS one.
[60] A. Ananthakrishnan,et al. Genetic risk factors for Clostridium difficile infection in ulcerative colitis , 2013, Alimentary pharmacology & therapeutics.
[61] M. Wilkins,et al. Comparative genomics of Campylobacter concisus isolates reveals genetic diversity and provides insights into disease association , 2013, BMC Genomics.
[62] O. Bulut,et al. Pathogenic Yersinia DNA in Intestinal Specimens of Pediatric Patients with Crohn's Disease , 2013, Fetal and pediatric pathology.
[63] S. Hanauer,et al. Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's disease , 2013, Alimentary pharmacology & therapeutics.
[64] E. El-Omar,et al. The Microaerophilic Microbiota of De-Novo Paediatric Inflammatory Bowel Disease: The BISCUIT Study , 2013, PloS one.
[65] Xuhang Li,et al. Childhood Helminth Exposure Is Protective Against Inflammatory Bowel Disease: A Case Control Study in South Africa , 2013, Inflammatory bowel diseases.
[66] P. Austin,et al. Impact of Clostridium difficile colitis on 5‐year health outcomes in patients with ulcerative colitis , 2012, Alimentary pharmacology & therapeutics.
[67] Y. Belkaid,et al. Acute Gastrointestinal Infection Induces Long-Lived Microbiota-Specific T Cell Responses , 2012, Science.
[68] U. Navaneethan,et al. Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis. , 2012, Journal of Crohn's & colitis.
[69] V. Villanacci,et al. Intestinal superinfections in patients with inflammatory bowel diseases. , 2012, Journal of Crohn's & colitis.
[70] P. Klemola,et al. Enteric viral pathogens in children with inflammatory bowel disease , 2012, Journal of medical virology.
[71] M. Wilkins,et al. The Pathogenic Potential of Campylobacter concisus Strains Associated with Chronic Intestinal Diseases , 2011, PloS one.
[72] J. Arola,et al. Human herpesvirus 6 and cytomegalovirus in ileocolonic mucosa in inflammatory bowel disease , 2011, Scandinavian journal of gastroenterology.
[73] S. Mazmanian,et al. Pathobionts of the gastrointestinal microbiota and inflammatory disease. , 2011, Current opinion in immunology.
[74] M. Riddle,et al. Detection bias and the association between inflammatory bowel disease and Salmonella and Campylobacter infection , 2011, Gut.
[75] E. El-Omar,et al. Detection of Campylobacter concisus and Other Campylobacter Species in Colonic Biopsies from Adults with Ulcerative Colitis , 2011, PloS one.
[76] A. Ananthakrishnan,et al. Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease , 2011, Inflammatory bowel diseases.
[77] U. Navaneethan,et al. Impact of Clostridium difficile infection in patients with ulcerative colitis. , 2011, Journal of Crohn's & colitis.
[78] I. Grishina,et al. Epstein-Barr virus replication linked to B cell proliferation in inflamed areas of colonic mucosa of patients with inflammatory bowel disease. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[79] E. Szigethy,et al. Inflammatory bowel disease. , 2011, Pediatric clinics of North America.
[80] K. T. Jørgensen,et al. Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease , 2010, Gut.
[81] Si Ming Man,et al. Detection of Helicobacteraceae in Intestinal Biopsies of Children with Crohn’s Disease , 2010, Helicobacter.
[82] M. Vatn,et al. Paucity of mycobacteria in mucosal bowel biopsies from adults and children with early inflammatory bowel disease. , 2010, Journal of Crohn's & colitis.
[83] M. Diebold,et al. Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases , 2010, Journal of medical virology.
[84] A. Ananthakrishnan,et al. Impact of Clostridium difficile on inflammatory bowel disease , 2010, Expert review of gastroenterology & hepatology.
[85] R. Xavier,et al. Virus-Plus-Susceptibility Gene Interaction Determines Crohn's Disease Gene Atg16L1 Phenotypes in Intestine , 2010, Cell.
[86] Si Ming Man,et al. Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease , 2010, Inflammatory bowel diseases.
[87] M. Dave,et al. Association between Helicobacter pylori infection and inflammatory bowel disease: A meta‐analysis and systematic review of the literature† , 2010, Inflammatory bowel diseases.
[88] M. Abreu,et al. Clinical Outcomes of Patients with Ulcerative Colitis and Co-existing Clostridium difficile Infection , 2010, Digestive Diseases and Sciences.
[89] Thomas F. Tedder,et al. Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism , 2009, Science.
[90] R. P. Ross,et al. The Vexed Relationship Between Clostridium Difficile and Inflammatory Bowel Disease: An Assessment of Carriage in an Outpatient Setting Among Patients in Remission , 2009, The American Journal of Gastroenterology.
[91] J. Ellingson,et al. Absence of mycobacterium avium subsp. paratuberculosis in Crohn's patients , 2009, Inflammatory bowel diseases.
[92] D. Elliott,et al. Helminths and the IBD hygiene hypothesis , 2009, Inflammatory bowel diseases.
[93] M. I. Nassar,et al. Acute Cytomegalovirus Infection Is a Risk Factor in Refractory and Complicated Inflammatory Bowel Disease , 2009, Digestive Diseases and Sciences.
[94] Si Ming Man,et al. Detection and Isolation of Campylobacter Species Other than C. jejuni from Children with Crohn's Disease , 2008, Journal of Clinical Microbiology.
[95] G. Kaplan,et al. A National Survey of the Prevalence and Impact of Clostridium difficile Infection Among Hospitalized Inflammatory Bowel Disease Patients , 2008, The American Journal of Gastroenterology.
[96] W. Weichert,et al. Fungi and inflammatory bowel diseases: Alterations of composition and diversity , 2008, Scandinavian journal of gastroenterology.
[97] A. Ananthakrishnan,et al. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease , 2007, Gut.
[98] Kimberly A. Reske,et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[99] H. Ogata,et al. Cytomegalovirus Is Frequently Reactivated and Disappears Without Antiviral Agents in Ulcerative Colitis Patients , 2007, The American Journal of Gastroenterology.
[100] B. Lashner,et al. Cytomegalovirus Colitis Complicating Inflammatory Bowel Disease , 2006, The American Journal of Gastroenterology.
[101] H. Nagawa,et al. Cytomegalovirus infection in ulcerative colitis , 2006, Scandinavian journal of gastroenterology.
[102] T. Giese,et al. High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn’s disease , 2005, Gut.
[103] Joel V Weinstock,et al. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. , 2005, Gastroenterology.
[104] Robert W. Summers,et al. Vomiting in the recently anticoagulated patient , 2004, Gut.
[105] S. Finkelstein,et al. Absence of Mycobacterium avium subsp. paratuberculosis in the microdissected granulomas of Crohn's disease , 2004, Modern Pathology.
[106] D. Rampton,et al. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool , 2004, European journal of gastroenterology & hepatology.
[107] C. Bernstein,et al. Study of Animal-Borne Infections in the Mucosas of Patients with Inflammatory Bowel Disease and Population-Based Controls , 2003, Journal of Clinical Microbiology.
[108] M. Bronner,et al. Pathogenic Yersinia DNA Is Detected in Bowel and Mesenteric Lymph Nodes From Patients With Crohn's Disease , 2003, The American journal of surgical pathology.
[109] D. Elliott,et al. The possible link between de-worming and the emergence of immunological disease. , 2002, The Journal of laboratory and clinical medicine.
[110] P. Malfertheiner,et al. Influence of anti‐Helicobacter triple‐therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora , 2001, Alimentary pharmacology & therapeutics.
[111] G. Pietrosi,et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis , 2001, American Journal of Gastroenterology.
[112] Wangxue Chen,et al. Detection of Listeria monocytogenes by polymerase chain reaction in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls , 2000, Journal of gastroenterology and hepatology.
[113] A. West,et al. Immunocytochemical evidence of Listeria, Escherichia coil, and Streptococcus antigens in Crohn's disease , 1995, Gastroenterology.
[114] M. Scheurlen,et al. Microbic Superinfection in Relapse of Inflammatory Bowel Disease , 1992, Journal of clinical gastroenterology.
[115] R. Pounder,et al. Clostridium difficile and inflammatory bowel disease. , 1983, Gut.